Pyridine-2-carboxamides for Mo-Catalyzed Asymmetric Allylic Alkylations
substitutions,[12] no product formation was observed when
monoamide 1e, derived from a 2-amino-4,6-O-benzylidene-
2-deoxyglucoside scaffold, was used as ligand. This suggests
that the NH function in position 3 is essential for the reac-
tion, and hence, diastereomer A should be the actual inter-
mediate.
lected organic phases were dried with sodium sulfate, and the sol-
vent was evaporated to afford ligands 1a (245 mg, 77%) and 1c
(225 mg, 82%). Use of the ligands in the catalytic reactions did
not require any further purification. Recrystallization of 1a from
methanol afforded 136 mg (43%) of the product. Ligand 1a: [α]2D0
1
= +107 (c = 0.1, CHCl3). H NMR (400 MHz, CDCl3): δ = 8.53
(d, J = 4.4 Hz, 1 H, H6-py), 8.52 (d, J = 10.4 Hz, 1 H, NH), 8.38
(d, J = 4.7 Hz, 1 H, H6-py), 8.10 (d, J = 10.4 Hz, 1 H, NH), 7.97
(d, J = 7.8 Hz, 1 H, H3-py), 7.90 (d, J = 7.8 Hz, 1 H, H3-py), 7.66–
7.62 (m, 2 H, H4-py), 7.36–7.30 (m, 4 H, H5-py and Ph H), 7.28–
7.16 (m, 8 H, Ph), 5.50 (s, 1 H, OCHO), 4.97 (d, J = 3.6 Hz, 1 H,
H1), 4.81 (q, J = 10.4 Hz, 1 H, H3), 4.77 (d, J = 12.2 Hz, 1 H,
CHHPh), 4.58 (dt, J = 10.4, 3.6 Hz, 1 H, H2), 4.54 (d, J = 12.2 Hz,
1 H, CHHPh), 4.22 (dd, J = 10.2, 4.9 Hz, 1 H, H6eq), 4.06 (dt, J
= 9.9, 4.9 Hz, 1 H, H5), 3.86 (dd, J = 10.2, 9.9 Hz, 1 H, H6ax),
3.76 (t, J = 10.3 Hz, 1 H, H4) ppm. 13C NMR (100 MHz, CDCl3):
δ = 165.5, 165.1, 149.9, 149.8, 148.7, 148.3, 137.6 (2 C, overlapped),
137.4 (2 C, overlapped), 129.3, 128.8, 128.6, 128.4, 128.3, 126.7,
126.5, 126.4, 122.7, 122.6, 102.2, 97.5, 80.3, 70.2, 69.5, 64.6, 53.4,
50.7 ppm. C32H30N4O6 (566.6): calcd. C 67.83, H 5.34, N 9.89;
found C 67.01, H 5.31, N 9.77. Ligand 1c: [α]2D0 = –121 (c = 0.1,
Figure 1. Diastereomeric complexes differing in the mode of coord-
iantion of 1a to Mo.
1
CHCl3). H NMR (400 MHz, CDCl3): δ = 8.57 (d, J = 4.8 Hz, 1
H, H6-py), 8.45 (d, J = 10 Hz, 1 H, NH), 8.29 (d, J = 4.7 Hz, 1
H, H6-py), 8.11 (d, J = 7.9 Hz, 1 H, H3-py), 8.09 (d, J = 10 Hz, 1
H, NH), 8.03 (d, J = 7.9 Hz, 1 H, H3-py), 7.76 (t, J = 7.9 Hz, 1
H, H4-py), 7.71 (t, J = 7.9 Hz, 1 H, H4-py), 7.40 (dd, J = 7.9,
4.7 Hz, 1 H, H5-py), 7.41–7.36 (m, 2 H, Ph), 7.26–7.22 (m, 4 H,
H5-py and Ph H), 5.58 (s, 1 H, OCHO), 4.93–4.86 (m, 2 H, H2,
H3), 4.69 (s, 1 H, H1), 4.27 (dd, J = 10.3, 4.8 Hz, 1 H, H6eq), 4.07
(dt, J = 9.9, 4.8 Hz, 1 H, H5), 3.90–3.85 (m, 2 H, H4, H6ax), 3.40
(s, 3 H, OCH3) ppm. 13C NMR (100 MHz, CDCl3): δ = 164.4 (2
C, overlapped), 149.4, 149.1, 148.0, 147.6, 137.3, 137.0 (2 C over-
lapped), 128.9, 128.0, 126.4, 126.1, 125.9, 122.3 (2 C, overlapped),
102.1, 100.8, 77.1, 68.8, 64.1, 55.0, 51.7, 48.1 ppm.
Conclusions
Bis(pyridine-2-carboxamides) were conveniently pre-
pared from 1,2-diamines obtained from α--glucose and α-
-mannose according to known procedures and shown to
serve as efficient ligands in Mo-catalyzed microwave-medi-
ated asymmetric allylic alkylations. The two types of struc-
tures allowed the comparison of ligands having the amide
arms in trans and cis positions in the six-membered ring.
The former type of ligands proved to be more successful,
providing the product, (+)-(R)-dimethyl 3-phenyl-1-butene-
4,4-dicarboxylate, with 99% enantiomeric excess and with
a branched/linear ratio of 49:1 in 90% isolated yield under
optimized conditions.
Synthesis of Ligand 1b: 4-Chloropyridine-2-carboxylic acid hydro-
chloride (285 mg, 1.14 mmol), 1,1Ј-carbonyldiimidazole (185 mg,
1.14 mmol) and potassium carbonate (158 mg, 1.14 mmol) were
mixed at 50 °C in dry tetrahydrofuran (2 mL) under nitrogen, and
the suspension obtained was stirred for 1 h. Then the glucosediam-
ine (200 mg, 0.56 mmol) was added, and the mixture was stirred at
the same temperature for an additional 1 h. The crude product was
concentrated under rotatory evaporation and purified by column
chromatography on silica gel (eluent: hexane/AcOEt, from 1:1 to
3:7) to yield 113 mg (32%) of the pure product. Additional ligand
was eluted together with an unidentified product. [α]2D0 = +12 (c =
0.1, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 8.43 (d, J = 5.2 Hz,
1 H, H6-py), 8.40 (d, J = 9.8 Hz, 1 H, NH), 8.26 (d, J = 5.6 Hz, 1
H, H6-py), 8.01 (d, J = 9.3 Hz, 1 H, NH), 7.96 (s, 1 H, H3), 7.91
(s, 1 H, H3), 7.36–7.28 (m, 4 H, H5 and Ph H), 7.27–7.12 (m, 8 H,
Ph), 5.49 (s, 1 H, OCHO), 4.94 (d, J = 3.5 Hz, 1 H, H1), 4.76 (q,
J = 9.8 Hz, 1 H, H3), 4.75 (d, J = 12.2 Hz, 1 H, CHHPh), 4.52 (d,
J = 12.2 Hz, 1 H, CHHPh), 4.53 (dt, J = 9.3, 3.5 Hz, 1 H, H2),
4.22 (dd, J = 10.3, 4.8 Hz, 1 H, H6eq), 4.09–4.02 (m, 1 H, H5), 3.78
(t, J = 9.8 Hz, 1 H, H6ax), 3.73 (t, J = 10.3 Hz, 1 H, H4) ppm. 13C
NMR (100 MHz, CDCl3): δ = 164.4, 164.0, 151.2, 151.1, 149.7,
149.2, 146.0 (2 C overlapped), 137.5, 137.2, 129.4, 128.9, 128.6 (2
C overlapped), 128.5, 128.4, 126.8, 126.7, 123.3 (2 C overlapped),
102.2, 97.3, 80.1, 70.3, 69.4, 64.6, 53.4, 50.9 ppm.
Experimental Section
General: THF and toluene were dried by using a Glass-contour
solvent dispensing system. Dichloromethane was distilled from
CaH2. Microwave heating was performed by using a Smith Cre-
1
ator single-mode cavity from Biotage. H NMR spectra were re-
corded at 400 or 300 MHz, and 13C NMR spectra at 100 or
75.3 MHz. The H and 13C chemical shifts are reported relative to
1
CHCl3.
Synthesis of Ligands 1a and 1c: A suspension of picolinic acid
(138 mg, 1.12 mmol) and 1,1Ј-carbonyldiimidazole (182 mg,
1.12 mmol) in dry tetrahydrofuran (2 mL) was heated in a flame-
dried flask at 50 °C under nitrogen for 1 h. Then the appropriate
diamine (0.56 mmol) was added, and the mixture was stirred at the
same temperature for 2 h. The solvent was removed under vacuum
and the residue extracted with dichloromethane. The organic phase
was extracted with water (3ϫ5 mL) and the aqueous phases were
combined and extracted with dichloromethane (2ϫ5 mL). The col-
Synthesis of Ligand 1e: A solution of picolinic acid (520 mg,
4.2 mmol), 4-(dimethylamino)pyridine (48 mg, 0.43 mmol) and 1,3-
dicyclohexylcarbodiimide (890 mg, 4.3 mmol) in dry dichlorometh-
ane (7 mL) was added to a solution of benzyl 2-amino-2-deoxy-
4,6-O-(4-methoxybenzylidene)-α--glucopyranoside,[21] (2.0 mmol)
Eur. J. Org. Chem. 2009, 1352–1356
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
1355